HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

6-N-hydroxylaminopurine

Also Known As:

N(6)-hydroxyaminopurine; N(6)-hydroxylaminopurine; N-hydroxyadenine

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Adenine: 2120
        6-N-hydroxylaminopurine: 3

Experts

1.	Kozmin, Stanislav G: 2 articles (10/2013 - 04/2008)
2.	Schaaper, Roel M: 2 articles (10/2013 - 04/2008)
3.	Stepchenkova, Elena I: 1 article (10/2013)
4.	Leroy, Prune: 1 article (04/2008)
5.	Pavlov, Youri I: 1 article (04/2008)

Related Diseases

1.	Hypersensitivity (Allergy) 10/01/2013 - "Lack of molybdenum cofactor (Moco) in Escherichia coli leads to hypersensitivity to the mutagenic and toxic effects of N-hydroxylated base analogs, such as 6-N-hydroxylaminopurine (HAP). " 04/01/2008 - "We have shown previously that lack of molybdenum cofactor (MoCo) in Escherichia coli leads to hypersensitivity to the mutagenic and toxic effects of N-hydroxylated base analogues, such as 6-N-hydroxylaminopurine (HAP). "
2.	Neoplasms (Cancer) 01/01/1985 - "2-Aminopurine is much less potent than 6-N-hydroxylaminopurine in inducing gene mutation in mammalian cells in culture and this corresponds to the relative activity of these two compounds in inducing tumors in rats and neoplastic transformation of Syrian hamster embryo cells in culture. "

Related Drugs and Biologics

1.	molybdopterin (molybdenum cofactor)
2.	2-Aminopurine (2 Aminopurine)